542678 Stock Overview
Cian Healthcare Limited engages in the research, development, manufacture, marketing, and sale of pharmaceutical products in India.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Cian Healthcare Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹21.23 |
| 52 Week High | ₹41.10 |
| 52 Week Low | ₹16.05 |
| Beta | 0.28 |
| 1 Month Change | 2.91% |
| 3 Month Change | -9.12% |
| 1 Year Change | -36.19% |
| 3 Year Change | 33.61% |
| 5 Year Change | n/a |
| Change since IPO | -65.48% |
Recent News & Updates
Recent updates
Shareholder Returns
| 542678 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -0.8% | 1.4% | 2.8% |
| 1Y | -36.2% | 57.2% | 46.6% |
Return vs Industry: 542678 underperformed the Indian Pharmaceuticals industry which returned 57.2% over the past year.
Return vs Market: 542678 underperformed the Indian Market which returned 46.6% over the past year.
Price Volatility
| 542678 volatility | |
|---|---|
| 542678 Average Weekly Movement | 5.9% |
| Pharmaceuticals Industry Average Movement | 5.9% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 542678 has not had significant price volatility in the past 3 months.
Volatility Over Time: 542678's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | 275 | Suraj Zanwar | cian.co |
Cian Healthcare Limited engages in the research, development, manufacture, marketing, and sale of pharmaceutical products in India. The company offers pharmaceutical products in various therapeutic areas of orthopedics, gynecology, pediatrics, cardiac, diabetic, dermatology, pain management, antibiotics, neuro, critical care, gastro-intestinal, and nutraceuticals. It also provides male and female infertility, energy and immunity boosting, protein supplement, arthritis and joint pain, hepatoprotective, haematinic, and pet care products, as well as herbal supplement, cosmetics, and hospital products.
Cian Healthcare Limited Fundamentals Summary
| 542678 fundamental statistics | |
|---|---|
| Market cap | ₹530.66m |
| Earnings (TTM) | ₹752.00k |
| Revenue (TTM) | ₹634.33m |
705.7x
P/E Ratio0.8x
P/S RatioIs 542678 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 542678 income statement (TTM) | |
|---|---|
| Revenue | ₹634.33m |
| Cost of Revenue | ₹306.96m |
| Gross Profit | ₹327.37m |
| Other Expenses | ₹326.62m |
| Earnings | ₹752.00k |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.03 |
| Gross Margin | 51.61% |
| Net Profit Margin | 0.12% |
| Debt/Equity Ratio | 103.7% |
How did 542678 perform over the long term?
See historical performance and comparison